financetom
Business
financetom
/
Business
/
MarketAxess Average Daily Volume Rises in November vs Year Ago
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MarketAxess Average Daily Volume Rises in November vs Year Ago
Dec 4, 2024 6:12 AM

08:37 AM EST, 12/04/2024 (MT Newswires) -- MarketAxess Holdings ( MKTX ) said Wednesday its total average daily volume came in at $44.95 billion in November, up 56% from a year earlier but down 3% compared to October.

Total rates ADV was $30.7 billion in November, up 112% from a year ago, but down 2% compared to October, the company said.

High-grade credit ADV was $6.53 billion in November, compared with $6.52 billion a year earlier, while high-yield credit ADV was $1.31 billion last month, compared to $1.91 billion a year ago, the company said.

MarketAxess ( MKTX ) shares fell more than 3% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Midday Gainers
Top Midday Gainers
Mar 8, 2024
02:21 PM EST, 03/08/2024 (MT Newswires) -- HCI Group ( HCI ) shares rose 13% after the company reported late Thursday Q4 results that topped analysts' estimates. More than 460,000 shares traded intraday compared with a daily average of about 104,000. Smith & Wesson Brands ( SWBI ) reported late Thursday stronger-than-expected Q3 results. Shares surged 28% as intraday trading...
FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risks
FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risks
Mar 8, 2024
(Reuters) - The U.S. FDA has approved Novo Nordisk's Wegovy for use in lowering the risk of stroke and heart attack in overweight or obese adults who are not diabetic, the Danish drugmaker said on Friday. Novo's widely used diabetes drug Ozempic and weight-loss drug Wegovy, both chemically known as semaglutide, belong to a class of drugs called GLP-1 agonists....
General Motors Resumes Chevrolet Blazer EV Sales at Lowered Prices
General Motors Resumes Chevrolet Blazer EV Sales at Lowered Prices
Mar 8, 2024
02:29 PM EST, 03/08/2024 (MT Newswires) -- General Motors ( GM ) said Friday it is resuming sales of its electric Chevrolet Blazer at reduced prices. This comes after a nearly three-month halt due to software issues. The automaker said in a statement to MT Newswires that it made significant software updates to improve the electric vehicle's features and functionality...
BMO Reviews AutoCanada's Q4 -- Trims Target by $1, to $23
BMO Reviews AutoCanada's Q4 -- Trims Target by $1, to $23
Mar 8, 2024
02:20 PM EST, 03/08/2024 (MT Newswires) -- AutoCanada's ( AOCIF ) Q4/23 headline EPS miss was due to unusual items in opex and higher-than-forecast underlying opex. The other parts of ACQ's Canadian business performed largely in line with BMO's expectations. The stock is trading at 6x BMO's revised 2025E EBITDA vs. historical range of 6-8x. Analyst Tamy Chen wonders if...
Copyright 2023-2026 - www.financetom.com All Rights Reserved